Blue Heron Capital
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Blue Heron Capital.
Key people at Blue Heron Capital.
Key people at Blue Heron Capital.
Blue Heron Capital is an early-stage growth equity investment firm specializing in healthcare and technology sectors. Their mission centers on partnering with innovative companies that leverage technology to improve healthcare delivery, reduce costs, and enhance patient experiences, particularly focusing on scalable B2B platforms with strong customer relationships and high switching costs. They combine financial capital with operational expertise through their OA Collaborative network to actively support portfolio companies’ growth and impact in the startup ecosystem[2][3][4].
Founded in 2006 and based in Richmond, VA, Blue Heron Capital was co-founded by Andrew Tichenor and Gordon Crenshaw, among others. Over time, the firm has evolved to focus on small-cap, high-growth healthcare and enterprise technology companies, typically investing in businesses with $3-$20 million in revenue that demonstrate capital efficiency, strong gross margins, and scalable business models. Their approach emphasizes minority growth equity investments in companies led by experienced management teams open to active investor involvement[2][4][5].
Blue Heron Capital rides the wave of digital transformation in healthcare, addressing critical trends such as cost containment, aging in place, and patient-centric care through technology innovation. The timing is favorable due to increasing demand for healthcare efficiency and technology adoption accelerated by demographic shifts and regulatory pressures. By investing in scalable B2B platforms with strong customer retention, Blue Heron influences the ecosystem by enabling companies that improve healthcare outcomes and operational efficiencies, thus contributing to the modernization of healthcare delivery systems[2][3].
Looking ahead, Blue Heron Capital is poised to deepen its impact by continuing to back innovative healthcare and enterprise technology companies that align with evolving market needs such as telehealth, digital patient engagement, and cost-effective care models. Trends like AI integration in healthcare and remote patient monitoring will likely shape their investment focus. Their combination of financial resources and operational expertise positions them to remain influential in driving growth and disruption in healthcare technology, reinforcing their role as a key growth equity partner in this dynamic sector[2][3].
In summary, Blue Heron Capital is a growth equity firm distinguished by its sector focus, active partnership model, and commitment to scaling technology-driven healthcare solutions that address pressing systemic challenges.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2025 | Adpipe | $12.0M Series A | — | — |
| Mar 1, 2025 | BlackCloak | $500K Venture Round | — | Thomas Noonan |
| Sep 1, 2024 | BlackCloak | $17.0M Series B | — | 20VC, Albion VC, Core Innnovation Capital, DFJ, Global Founders Capital, Nexus Venture Partners, Pear VC, Stride VC, Ulu Ventures, Akshay Kothari, Girish Mathrubootham, Thomas Noonan |
| Feb 1, 2024 | Redi.Health | $14.0M Series B | — | Alumni Ventures, Ascend Venture Capital, Bascom Ventures, Collaborative Seed & Growth Partners, Refinery Ventures, Marco A. Casas |
| Jan 1, 2024 | Corral Technologies | $1.0M Venture Round | — | Invest Nebraska, M25 |
| Dec 1, 2023 | Adpipe | $6.0M Series A | — | — |
| Feb 1, 2023 | Adpipe | $3.0M Seed | — | — |
| Jan 1, 2023 | Authenticx | $20.0M Series B | — | Bedrock Capital, FluidTheory, Left Lane Capital, M25 |
| Nov 1, 2022 | Yes Hearing | $10.0M Series A | — | Matthew Bressler |
| Oct 1, 2021 | Kion | $10.0M Series A | — | 3TS Capital Partners |
| Oct 1, 2017 | STARC Systems | $4.0M Venture Round | — | — |
